Table 2.
Stratification analysis of M-MDSC and MΦ in subtype DLBCL patients and healthy controls
| GCB-DLBCL (n=63) | Non-GCB-DLBCL (n=81) | Control (n=30) | |||||
|---|---|---|---|---|---|---|---|
|
|
|
||||||
| Very good prognosis (9) | Good prognosis (27) | Poor prognosis (27) | Very good prognosis (12) | Good prognosis (30) | Poor prognosis (39) | ||
| M-MDSC (%) | 5.53±1.00 | 8.25±0.71 | 11.08±1.49 | 6.98±0.86 | 8.84±0.50 | 12.68±0.96 | 2.46±0.26 |
| MΦ (%) | 0.050±0.010 | 0.073±0.015 | 0.089±0.013 | 0.063±0.010 | 0.077±0.011* | 0.139±0.042* | 0.053±0.018 |
*
denotes statistical significance compared with GCB-DLBCL counterparts.